Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-14-033121)

Filing Details

Accession Number:: 0001209191-14-033121
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-05-12 20:23:39
Reporting Period:: 2014-05-08

Filing Date:: 2014-05-12
Accepted Time:: 2014-05-12 20:23:39
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1088856	Corcept Therapeutics Inc	CORT	Pharmaceutical Preparations (2834)	770487658

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1236397	Daniel Bradbury	C/O Corcept 149 Commonwealth Drive Menlo Park CA 94025		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-05-09	125,000	$1.79	304,000	No	4	P	Indirect	BioBrit,LLC.
Common Stock	Acquisiton	2014-05-12	13,925	$1.83	317,925	No	4	P	Indirect	BioBrit, LLC.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	BioBrit,LLC.
No	4	P	Indirect	BioBrit, LLC.

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock option (right to buy)	Acquisiton	2014-05-08	30,000	$1.74	30,000	$1.74

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
30,000		2024-05-08	No	4	A	Direct

Footnotes

Represents the average price per share
Exercisable with respect to 8.3334% of the total option shares on each monthly anniversary of May 8, 2014, with the final vesting of all remaining shares to occur on or before the date of Corcept's 2015 Annual Meeting of Stockholders.